Literature DB >> 11834617

Alpha 2-adrenoceptors in the enteric nervous system: a study in alpha 2A-adrenoceptor-deficient mice.

Jens Scheibner1, Anne-Ulrike Trendelenburg, Lutz Hein, Klaus Starke, Corrado Blandizzi.   

Abstract

Mammals possess three types of alpha(2)-adrenoceptor, alpha(2A), alpha(2B) and alpha(2C). Our aim was to determine the type of alpha(2)-adrenoceptor involved in the control of gastrointestinal motility. In transmitter overflow experiments, myenteric plexus longitudinal muscle (MPLM) preparations of the ileum were preincubated with [(3)H]-choline and then superfused. The alpha(2)-adrenoceptor agonist medetomidine reduced the electrically evoked overflow of tritium from preparations taken from wild type but not alpha(2A)-adrenoceptor-knockout mice. In a second series of overflow experiments, MPLM preparations were preincubated with [(3)H]-noradrenaline and then superfused. Again medetomidine reduced the electrically evoked overflow of tritium from wild type but not alpha(2A)-knockout preparations. In organ bath experiments, medetomidine reduced electrically evoked contractions of segments of the ileum from wild type but not alpha(2A)-knockout mice. In each of these three series, phentolamine antagonized the effect of medetomidine in wild-type preparations with greater potency than rauwolscine. In conscious mice, gastrointestinal transit was assessed by means of an intragastric charcoal bolus. In alpha(2A)-knockout mice, the speed of gastrointestinal transit was doubled compared to wild-type. Medetomidine, injected intraperitoneally, slowed gastrointestinal transit in wild type but not alpha(2A)-knockout mice. We conclude that the cholinergic motor neurons of the enteric nervous system of mice possess alpha(2)-heteroreceptors which mediate inhibition of acetylcholine release, of neurogenic contractions and of gastrointestinal transit. The noradrenergic axons innervating the intestine possess alpha(2)-autoreceptors. Both hetero- and autoreceptors are exclusively alpha(2A). It is the alpha(2A)-adrenoceptor which in vivo mediates the inhibition of intestinal motility by the sympathetic nervous system.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11834617      PMCID: PMC1573176          DOI: 10.1038/sj.bjp.0704512

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  35 in total

Review 1.  Transgenic models of alpha 2-adrenergic receptor subtype function.

Authors:  L Hein
Journal:  Rev Physiol Biochem Pharmacol       Date:  2001       Impact factor: 5.545

Review 2.  The enteric nervous system and regulation of intestinal motility.

Authors:  W A Kunze; J B Furness
Journal:  Annu Rev Physiol       Date:  1999       Impact factor: 19.318

3.  Role of alpha(2)-adrenoceptors in the sympathetic inhibition of motility reflexes of guinea-pig ileum.

Authors:  M Stebbing; P Johnson; M Vremec; J Bornstein
Journal:  J Physiol       Date:  2001-07-15       Impact factor: 5.182

4.  Role of alpha 2-adrenoceptors in the regulation of intestinal water transport.

Authors:  L Liu; I M Coupar
Journal:  Br J Pharmacol       Date:  1997-03       Impact factor: 8.739

5.  Abnormal regulation of the sympathetic nervous system in alpha2A-adrenergic receptor knockout mice.

Authors:  J D Altman; A U Trendelenburg; L MacMillan; D Bernstein; L Limbird; K Starke; B K Kobilka; L Hein
Journal:  Mol Pharmacol       Date:  1999-07       Impact factor: 4.436

6.  A re-investigation of questionable subclassifications of presynaptic alpha2-autoreceptors: rat vena cava, rat atria, human kidney and guinea-pig urethra.

Authors:  A U Trendelenburg; I Sutej; C A Wahl; G J Molderings; L C Rump; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1997-12       Impact factor: 3.000

7.  Alpha2-adrenoceptors modulating neuronal serotonin release: a study in alpha2-adrenoceptor subtype-deficient mice.

Authors:  J Scheibner; A U Trendelenburg; L Hein; K Starke
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

8.  The inhibitory effects of alpha(2)-adrenoceptor agonists on gastrointestinal transit during croton oil-induced intestinal inflammation.

Authors:  O Pol; L Valle; I Ferrer; M M Puig
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

9.  Effects of imidazoline derivatives on cholinergic motility in guinea-pig ileum: involvement of presynaptic alpha2-adrenoceptors or imidazoline receptors?

Authors:  R Colucci; C Blandizzi; D Carignani; G Placanica; G Lazzeri; M Del Tacca
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1998-06       Impact factor: 3.000

10.  Beta-3 adrenergic receptor agonists cause an increase in gastrointestinal transit time in wild-type mice, but not in mice lacking the beta-3 adrenergic receptor.

Authors:  D S Fletcher; M R Candelore; D Grujic; B B Lowell; S Luell; V S Susulic; D E Macintyre
Journal:  J Pharmacol Exp Ther       Date:  1998-11       Impact factor: 4.030

View more
  15 in total

1.  Investigation of the distribution and function of alpha-adrenoceptors in the sheep isolated internal anal sphincter.

Authors:  S J Rayment; T Eames; J A D Simpson; M R Dashwood; Y Henry; H Gruss; A G Acheson; J H Scholefield; V G Wilson
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

2.  Dynamics of fast synaptic excitation during trains of stimulation in myenteric neurons of guinea-pig ileum.

Authors:  Jianhua Ren; James J Galligan
Journal:  Auton Neurosci       Date:  2005-02-07       Impact factor: 3.145

3.  Altered prejunctional modulation of intestinal cholinergic and noradrenergic pathways by alpha2-adrenoceptors in the presence of experimental colitis.

Authors:  Corrado Blandizzi; Matteo Fornai; Rocchina Colucci; Fabio Baschiera; Giovanni Barbara; Roberto De Giorgio; Fabrizio De Ponti; Maria Cristina Breschi; Mario Del Tacca
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

4.  Association of distinct alpha(2) adrenoceptor and serotonin transporter polymorphisms with constipation and somatic symptoms in functional gastrointestinal disorders.

Authors:  H J Kim; M Camilleri; P J Carlson; F Cremonini; I Ferber; D Stephens; S McKinzie; A R Zinsmeister; R Urrutia
Journal:  Gut       Date:  2004-06       Impact factor: 23.059

5.  Intraganglionic laminar endings and their relationships with neuronal and glial structures of myenteric ganglia in the esophagus of rat and mouse.

Authors:  M Raab; W L Neuhuber
Journal:  Histochem Cell Biol       Date:  2004-09-18       Impact factor: 4.304

6.  alpha2A-adrenoceptor antagonism increases insulin secretion and synergistically augments the insulinotropic effect of glibenclamide in mice.

Authors:  V Fagerholm; M Scheinin; M Haaparanta
Journal:  Br J Pharmacol       Date:  2008-05-19       Impact factor: 8.739

7.  Candidate genes and sensory functions in health and irritable bowel syndrome.

Authors:  Michael Camilleri; Irene Busciglio; Paula Carlson; Sanna McKinzie; Duane Burton; Kari Baxter; Michael Ryks; Alan R Zinsmeister
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-05-29       Impact factor: 4.052

8.  Physiological modulation of intestinal motility by enteric dopaminergic neurons and the D2 receptor: analysis of dopamine receptor expression, location, development, and function in wild-type and knock-out mice.

Authors:  Zhi Shan Li; Claudia Schmauss; Abigail Cuenca; Elyanne Ratcliffe; Michael D Gershon
Journal:  J Neurosci       Date:  2006-03-08       Impact factor: 6.167

9.  Activity-dependent regulation of tyrosine hydroxylase expression in the enteric nervous system.

Authors:  J Chevalier; P Derkinderen; P Gomes; R Thinard; P Naveilhan; P Vanden Berghe; M Neunlist
Journal:  J Physiol       Date:  2008-02-07       Impact factor: 5.182

10.  Sympathetic Input to Multiple Cell Types in Mouse and Human Colon Produces Region-Specific Responses.

Authors:  Kristen M Smith-Edwards; Brian S Edwards; Christina M Wright; Sabine Schneider; Kimberly A Meerschaert; Lindsay L Ejoh; Sarah A Najjar; Marthe J Howard; Kathryn M Albers; Robert O Heuckeroth; Brian M Davis
Journal:  Gastroenterology       Date:  2020-09-24       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.